New diabetes pill shows Real-World blood sugar benefits
NCT ID NCT04601753
First seen Oct 31, 2025 · Last updated Apr 29, 2026 · Updated 23 times
Summary
This study looked at how well the once-daily pill Rybelsus (oral semaglutide) controls blood sugar in adults with type 2 diabetes. About 194 participants in Sweden took the medicine as prescribed by their doctor and filled out questionnaires during regular visits. The study lasted 8-10 months and measured changes in blood sugar levels and body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre for Sweden
Malmo, 202 15, Sweden
Conditions
Explore the condition pages connected to this study.